Department of Hematology, Oncology and Tumor Immunology, Molecular Cancer Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Best Pract Res Clin Haematol. 2012 Mar;25(1):3-12. doi: 10.1016/j.beha.2012.01.003. Epub 2012 Feb 8.
Diffuse large B-cell lymphoma and Burkitt lymphoma are two distinct lymphoma entities recognized by the current World Health Organization classification of lymphoid neoplasms. Although diagnostic criteria to distinguish these two subtypes have been established, a subset of cases have overlapping characteristics and therefore, the distinction can be challenging. Thus, the World Health Organization classification introduced an intermediate subtype referred as "B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma". This review summarizes our current understanding of the biology of these lymphoma subtypes.
弥漫性大 B 细胞淋巴瘤和伯基特淋巴瘤是目前世界卫生组织淋巴肿瘤分类中两种不同的淋巴瘤实体。尽管已经建立了区分这两种亚型的诊断标准,但仍有一部分病例具有重叠特征,因此区分具有挑战性。因此,世界卫生组织分类引入了一种中间亚型,称为“弥漫性大 B 细胞淋巴瘤和伯基特淋巴瘤之间特征的中间型 B 细胞淋巴瘤,不可分类”。这篇综述总结了我们目前对这些淋巴瘤亚型生物学特性的理解。